摘要
Abstract
ObjectiveTo analyze of the value of high flux hemodialysis and high flux hemodiafiltration on bone and mineral metabolism.MethodsThe clinical data of 60 cases with maintenance hemodialysis patients with end-stage renal disease were collected from December 2012 to December 2013 in our hospital. After the high-flux hemodialysis (HFHD) treatment,all the patients were given high-throughput hemodiafiltration (HFHDF) treatment, changes in the index of HFHD, after HFHDF 1 month, 3 months, six months were compared.ResultsThere was no significant difference in BMI, systolic blood pressure, diastolic blood pressure, Kt /V, BUN, Scr, UA, ALB among HFHD and after HFHDF 1 months, 3 months, 6months(P>0.05). There was no significant difference in the serum calcium, phosphorus and parathyroid hormone among HFHD and HFHDF 1 months, 3 months(P>0.05). The serum phosphorus and parathyroid hormone after HFHDF 6 months was lower than HFHD,there was significant difference (P<0.05). The serum calcium levels was lower than HFHD, but there was no significant difference (P>0.05). ConclusionPatients with end-stage renal disease using high flux hemodiafiltration, it can reduce blood phosphorus level, improve the secondary hyperparathyroidism and the prognosis. It is worthy of clinical promotion.关键词
高通量血液透析/高通量血液透析滤过/矿物质代谢Key words
High flux hemodialysis/High flux hemodiafiltration/Mineral metabolism分类
医药卫生
